Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adenosine vs Diltiazem for AVNRT after Failed Valsalva
NCT07456423Phase 4Completed
- Sponsor
- Haseki Training and Research Hospital
- Start
- Jul 2024
- Primary completion
- Jun 2025
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in Atrioventricular Nodal Reentrant Tachycardia (AVNRT) comparing Adenosine group with Diltiazem group (2 arms). Primary endpoint: Conversion to sinus rhythm on continuous cardiac monitor/ECG without rescue therapy at 20 minutes. Started Jul 2024; status: completed.
02
Drugs
adenosinediltiazem
03
Conditions
Atrioventricular Nodal Reentrant Tachycardia (AVNRT)
Beyond the preview
Go deeper on NCT07456423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07456423.